Home >> BRC News

BRC News

CBRC-funded projects have been showcased by the European Union for their work on antimicrobial drug resistance (AMR). The EU has been strongly committed to combating AMR for over 10 years and has prioritised research in this field. Projects showcased include two CBRC-supported projects at UCL: the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) and the ‘antiresdev’ project looking at the effects of antibiotic administration on the emergence and persistence of antibiotic-resistant bacteria.
The CBRC received a fantastic response to the funding call made in autumn 2010. After a robust peer review process, grants were awarded to projects from the infectious disease, neurotherapeutics, neurodiagnostics and cardiovascular disease themes.
Joint funding by the CBRC and University College London Hospital (UCLH) has enabled UCLH to install an advanced scanner specifically for translational research.
Researchers in the CBRC’s oral health theme have found that insufficient cleaning could allow build-up of potentially pathogenic microbes on orthodontic retainers.
Initial treatment for HIV is three times more likely to fail if a person is infected with transmitted drug resistant (TDR) HIV compared to non-resistant HIV, according to a European-wide study involving CBRC and UCL investigators.
CBRC investigator Professor Derek Yellon is one of 23 eminent researchers to be honoured with the status of National Institute of Health Research (NIHR) Senior Investigator in the latest round of NIHR appointments.